AI pioneer joins startup that wants you to snort nanoparticles
AI-summarised brief · reviewed before publication
Ray Kurzweil, a leading AI theorist, has joined neurotechnology startup Subsense, which is developing a non‑invasive brain‑computer interface that delivers charged nanoparticles through a nasal spray. The particles travel via the olfactory nerve to the brain, positioning near neurons to read and stimulate activity using external magnetic fields. Subsense has raised $27 million, completed mouse trials, and aims to treat neurological disorders such as Parkinson’s and ALS. The company positions itself as an alternative to surgical implants like Elon Musk’s Neuralink, potentially expanding BCI accessibility.
💡 Why It Matters
- · By bypassing surgery, the nasal‑spray BCI could lower barriers to widespread adoption, accelerating clinical trials and therapeutic applications that currently rely on costly, invasive procedures.